<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00477360</url>
  </required_header>
  <id_info>
    <org_study_id>15052007</org_study_id>
    <nct_id>NCT00477360</nct_id>
  </id_info>
  <brief_title>Humeral Resurfacing Hemiarthroplasty</brief_title>
  <acronym>CAP</acronym>
  <official_title>Humeral Resurfacing Hemiarthroplasty. Phase 2: Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DePuy International</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johnson &amp; Johnson</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to examine quality of life outcomes in patients who&#xD;
      have undergone a humeral surface replacement hemiarthroplasty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Resurfacing arthroplasty is gaining popularity for the reconstruction of advanced shoulder&#xD;
      arthritis. New generation re-surfacing prostheses are engineered to anatomically restore a&#xD;
      smooth articulating surface to the humeral head, while preserving bone stock, and potentially&#xD;
      minimizing the risk for diaphyseal fracture. The results for shoulder resurfacing prostheses&#xD;
      have largely been reported in retrospective reviews and have been very favorable. The purpose&#xD;
      of this multi-centered, prospective study will be to determine the extent to which patient&#xD;
      self-assessed outcomes (American Shoulder and Elbow Society (ASES) Score) following humeral&#xD;
      resurfacing improve compared to pre-operative ASES scores.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2007</start_date>
  <completion_date type="Anticipated">February 2013</completion_date>
  <primary_completion_date type="Anticipated">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>American Shoulder And Elbow Surgeons Shoulder Index (ASES)</measure>
    <time_frame>24 months post-operative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Constant Score</measure>
    <time_frame>24 months post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Western Ontario Osteoarthritis of the Shoulder Index (WOOS)</measure>
    <time_frame>24 months post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Simple Shoulder Test (SST)</measure>
    <time_frame>24 months post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Evaluation</measure>
    <time_frame>3 months + yearly post-operative</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Advanced Glenohumeral Arthritis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>C.A.P</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Humeral surface replacement hemiarthroplasty (CAP)</intervention_name>
    <description>C.A.P hemiarthroplasty</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Pre-Operative Inclusion Criteria:&#xD;
&#xD;
          -  Failed standard non-surgical management (analgesics, nsaids, physiotherapy, activity&#xD;
             modification)&#xD;
&#xD;
          -  Persistent pain and disability for at least 6 months&#xD;
&#xD;
          -  Imaging demonstrates advanced humeral head cartilage loss&#xD;
&#xD;
        Pre-Operative Exclusion Criteria:&#xD;
&#xD;
          -  Active or systemic joint infection&#xD;
&#xD;
          -  Significant muscle paralysis of shoulder girdle&#xD;
&#xD;
          -  Charcot's Arthropathy&#xD;
&#xD;
          -  Major medical illness (life expectancy &lt;2years)&#xD;
&#xD;
          -  Unable to speak and read English/French&#xD;
&#xD;
          -  Psychiatric illness that precludes informed consent&#xD;
&#xD;
          -  Unwilling/unable to remain in study for one year&#xD;
&#xD;
        Intra-Operative Inclusion Criteria:&#xD;
&#xD;
        Advanced humeral head cartilage loss AND ONE of:&#xD;
&#xD;
          -  minimal/no glenoid cartilage loss&#xD;
&#xD;
          -  complete glenoid cartilage loss and no bony erosion&#xD;
&#xD;
          -  complete glenoid cartilage loss and concentric bony erosion with no humeral&#xD;
             anterior/posterior subluxation&#xD;
&#xD;
        Intra-Operative Exclusion Criteria:&#xD;
&#xD;
          -  Eccentric glenoid erosion with biconcavity of glenoid and subluxation of humeral head&#xD;
&#xD;
          -  Inability of humeral head to support the CAP surface replacement&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Richard Boorman</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Calgary</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. Dianne Bryant</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Western Ontario, Canada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Calgary Sport Medicine Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 1N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <study_first_submitted>May 22, 2007</study_first_submitted>
  <study_first_submitted_qc>May 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2007</study_first_posted>
  <last_update_submitted>August 10, 2011</last_update_submitted>
  <last_update_submitted_qc>August 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Richard Boorman</name_title>
    <organization>University of Calgary</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

